166 filings
8-K
TTOO
T2 Biosystems Inc
22 May 24
Other Events
4:49pm
8-K
TTOO
T2 Biosystems Inc
20 May 24
Entry into a Material Definitive Agreement
7:00am
8-K
TTOO
T2 Biosystems Inc
14 May 24
Amendments to Articles of Incorporation or Bylaws
4:43pm
8-K
TTOO
T2 Biosystems Inc
7 May 24
Other Events
4:48pm
8-K
TTOO
T2 Biosystems Inc
6 May 24
T2 Biosystems Announces First Quarter 2024 Financial Results
5:24pm
8-K
3is11gaq4y9 s8wn
18 Apr 24
Entry into a Material Definitive Agreement
4:12pm
8-K
yj4ydjsa n38r
12 Apr 24
Submission of Matters to a Vote of Security Holders
4:47pm
8-K
atnh2e
28 Mar 24
Regulation FD Disclosure
4:31pm
8-K
8t803kopndzkdqny3
20 Mar 24
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates
9:17am
8-K
kyqqd6l ic1sj5lz5kt
18 Mar 24
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel
9:06am
8-K
c4uq43u3c 21
12 Mar 24
Other Events
9:00am
8-K
ka54n3ris9t
16 Feb 24
Results of Operations and Financial Condition
5:00pm
8-K
nnp9p1cq22ikdgrtbi
15 Feb 24
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results
4:47pm
8-K
5hle4i5xpt0dphvkbw
5 Jan 24
Departure of Directors or Certain Officers
4:00pm
8-K/A
wo54yu
24 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
dr9bn21zifjkmdb7
1 Nov 23
Other Events
9:08am
8-K
maeixxxp27ad
25 Oct 23
T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference
9:02am
8-K
jmqdsr k9y60jgm0o9
23 Oct 23
Entry into a Material Definitive Agreement
9:00am
8-K
5xpyqd 5wpcw2ilr
17 Oct 23
Results of Operations and Financial Condition
4:31pm
8-K
6p917y7q
12 Oct 23
T2 Biosystems Announces Preliminary Third Quarter 2023 Financial Results and Business Updates
4:32pm